Implanet announced initial positive results following use of the Jazz Lock® spinal implant in >25 cases. Full global launch is slated to occur by end of 2016.
Jazz Lock represents the first of a range of polyester band-based products to treat degenerative spinal conditions. The company announced FDA 510(k) clearance and CE Mark approval for the device in early 2Q16.
Implanet announced initial positive results following use of the Jazz Lock® spinal implant in >25 cases. Full global launch is slated to occur by end of 2016.
Jazz Lock represents the first of a range of polyester band-based products to treat degenerative spinal conditions. The company...
Implanet announced initial positive results following use of the Jazz Lock® spinal implant in >25 cases. Full global launch is slated to occur by end of 2016.
Jazz Lock represents the first of a range of polyester band-based products to treat degenerative spinal conditions. The company announced FDA 510(k) clearance and CE Mark approval for the device in early 2Q16.
Copy to clipboard 
